Jill Henrich, EVP, Chief Regulatory Officer at Atara Biotherapeutics, Inc. (ATRA), sold 1,059 shares at $7.00 ($7K) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Open-market sale of $7k ATRA by EVP, Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATRA | SELL | 2024-05-20 | $16K | — | Filing → |
| ATRA | SELL | 2024-03-06 | $3K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $1K | — | Filing → |